Selinexor and Ibrutinib in Treating Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia or Aggressive Non-Hodgkin Lymphoma
- Status
- COMPLETED
- Phase
- PHASE1
Clinical Trials Related to Selinexor
Related studies linked through entity extraction aliases.
Selinexor and Chemotherapy in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia
- Status
- COMPLETED
- Phase
- PHASE1
Selinexor in Combination With Irinotecan in Adenocarcinoma of Stomach and Distal Esophagus
- Status
- TERMINATED
- Phase
- PHASE1
Selective Inhibitor of Nuclear Export, Selinexor (KPT-330) in Combination With Paclitaxel and Carboplatin in Patients With Advanced Ovarian or Endometrial Cancers
- Status
- COMPLETED
- Phase
- PHASE1
KPT-330 to Treat Poorly Differentiated Lung and Gastroenteropancreatic Tumors
- Status
- COMPLETED
- Phase
- PHASE2
A Phase II Study of Selinexor Plus Cytarabine and Idarubicin in Patients With Relapsed/Refractory Acute Myeloid Leukemia (AML)
- Status
- COMPLETED
- Phase
- PHASE2
Selinexor (KPT-330) in Patients With Relapsed/Refractory Diffuse Large B-Cell Lymphoma (DLBCL)
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Selinexor in Treating Patients With Abiraterone Acetate and/or Enzalutamide Refractory Metastatic Castration-Resistant Prostate Cancer
- Status
- TERMINATED
- Phase
- PHASE2
Selinexor With Fludarabine and Cytarabine for Treatment of Refractory or Relapsed Leukemia or Myelodysplastic Syndrome
- Status
- COMPLETED
- Phase
- PHASE1
Selinexor, Carfilzomib, and Dexamethasone in Treating Patients With Relapsed or Refractory Multiple Myeloma
- Status
- COMPLETED
- Phase
- PHASE1
Selinexor (KPT-330) and Liposomal Doxorubicin For Relapsed and Refractory Multiple Myeloma
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Gemcitabine, Nab-paclitaxel and KPT-330 in Advanced Pancreatic Cancer
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
SHIP (Selinexor in Hormone Insensitive Prostate Cancer)
- Status
- TERMINATED
- Phase
- PHASE2
Selinexor in Initial or Refractory and/or Relapsed Richter's Transformation
- Status
- TERMINATED
- Phase
- PHASE2
Evaluating SINE KPT-330 in Treating Patients With Melanoma That Cannot Be Removed By Surgery
- Status
- COMPLETED
- Phase
- PHASE1
Decitabine and Selinexor in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia
- Status
- COMPLETED
- Phase
- PHASE1
Selinexor (KPT-330) in Older Patients With Relapsed AML
- Status
- COMPLETED
- Phase
- PHASE2
A Study of Drug Therapies for Salivary Gland Cancers Based on Testing of Genes
- Status
- COMPLETED
- Phase
- NA
Study of KPT-330 (Selinexor) in Female Patients With Advanced Gynaecologic Malignancies
- Status
- COMPLETED
- Phase
- PHASE2
Study Evaluating the Efficacy and Safety of Selinexor (KPT-330) in Participants With Recurrent Gliomas
- Status
- TERMINATED
- Phase
- PHASE2